Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Eutectic Crystallization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103694230A reveals amino acid eutectic purification for Canagliflozin. Achieve <0.5% alpha-impurity with scalable, cost-effective pharmaceutical intermediate solutions.
Patent CN103936727A details a novel purification method reducing alpha-impurities. This ensures supply chain reliability and cost efficiency for pharmaceutical intermediates.